China’s Health Ministry Gets Authority Over SFDA
This article was originally published in PharmAsia News
Drug regulation in China is now under the control of the country's Ministry of Health. The ministry took control of the State FDA, a move intended to improve the record of the agency that regulates pharmaceutical and food safety. The ministry also oversees China's hospitals and public health system. The State Council approved the change, which took effect immediately. The change means the ministry will be ultimate authority in matters of SFDA regulation, safety, policy and quality assessments. The move has its critics who are concerned about too much centralization leading to corruption and negligence. (Click here for more
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.